Chad vs Georgia: HIV-positive TB patients on ART (antiretroviral therapy)
Chad
100.0%
in 2024
Georgia
100.0%
in 2024
Chad rank
1st
Georgia rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Chad
- Georgia
How they compare
Chad currently reports 100.0% against 100.0% in Georgia, a difference of 0.0%.
The two have swapped places 2 times across 14 shared years of data; in 2010 it was Georgia ahead.
Chad ranks 1st and Georgia ranks 1st of 144 countries.
Across the 2 decades both report, Chad averaged higher in 1 and Georgia in 1.
Head to head by decade
| Decade | Chad | Georgia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 61.1% | 88.7% | 27.6% | Georgia |
| 2020s | 99.4% | 96.6% | 2.8% | Chad |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Chad or Georgia?
- Chad, at 100.0% against 100.0% in Georgia as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Chad and Georgia?
- 0.0%, with Chad ahead.
- How many years of comparable data are there for Chad and Georgia?
- 14 years are reported by both, from 2010 to 2024.
- How do Chad and Georgia rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Chad ranks 1st and Georgia ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.